$CHWY

Singh Sumit sold $995K of CHWY

Singh Sumit (Chief Executive Officer) sold 43,244 shares of Chewy, Inc. (CHWY) at $23.01 ($1.00M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Singh Sumit
Published Aug 4, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHWY
Neutral
high confidence
Mentioned
$CHWY
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHWYNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price ($23.0100/share), and total value ($995,044.44) reported on 2026-08-04 for a trade dated 2026-08-03, under a pre-arranged 10b5-1 plan.

02

Market read

This provides incremental sentiment context via insider selling, but it is not a fundamental catalyst.

03

What to watch

Traders may still watch for follow-on insider activity (additional Form 4s) or whether the sale coincides with other company-specific news, which is not present here.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-04, sale dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for Chewy, Inc. (CHWY) by CEO Sumit Singh.

Company-level read

Ticker impact

$CHWYNeutralHigh confidence
Context

Chewy CEO Sumit Singh sold 43,244 shares in an open-market transaction for about $995K under a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and outweighed by the 10b5-1 framing.

Evidence & confidence

Form 4 reports the sale details (size, price, date) but provides no new company fundamentals, guidance, or regulatory/legal development.

Market effects

Minimal; insider sale in a single consumer/retail name does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Chewy, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Singh Sumit

    CEO and director who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHWYHighAI 8/10

Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

$CHWYMed

Chewy Puts a $50 Million Price Tag on AI Productivity

Chewy expects AI to reduce costs by $50M in fiscal 2027, up from low tens of millions this year. CEO Sumit Singh attributes savings to AI tools in customer service, pharmacy, and veterinary care. The company's AI assistant, Cai, handles 30% of chats without human agents. AI tools also improve internal operations and pharmacy processes. Chewy built the AI infrastructure in-house, giving it a competitive advantage. The savings will offset wage inflation and fund growth initiatives.

$CHWYMed

Chewy rises as Goldman Sachs maintains Buy rating on stock

Chewy Inc. shares rose 6.78% to $19.06 after Goldman Sachs maintained a Buy rating but lowered its price target to $34 from $46. The company reported Q1 earnings beat but reduced its fiscal 2026 sales outlook, prompting multiple analysts to cut price targets. Chewy's stock is down 56.34% over the past year and trades near its 52-week low.

$CHWYMedAI 8/10

CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom?

Chewy (CHWY) shares rose 6% to $21.75, despite a 34% YTD decline. The company reported 7.3% sales growth, raised full-year revenue guidance, and maintained gross margin at 30.4%. Cash decreased to $611M due to acquisitions and share buybacks. The broader pet-care sector has underperformed, with the PAWZ ETF down 10% YTD. Investors await Q3 2026 results to assess margin expansion and potential bottom.

$CHWYMedAI 8/10

Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity?

Chewy (CHWY) reported Q2 2026 net sales of $3.33B, up 7.3%, and adjusted EPS of $0.36. The company raised its full-year outlook, but analysts downgraded the stock and cut price targets. CHWY stock fell 10% intraday after the results. Active customers rose 3.8% to 21.7M. Organic revenue growth slowed to 5.7%, and adjusted EBITDA margin benefited from non-recurring items. Analysts debate whether the slowdown is cyclical or structural.

$CHWYMedAI 8/10

CHWY Stock Hits Over 1-Month Low After Flat Q2 Gross Margin Overshadows Raised Outlook

Chewy Inc. (CHWY) reported Q2 net sales of $3.33B, up 7.3% YoY, meeting estimates. Adjusted EPS rose to $0.36, missing estimates by 1%. Gross margin remained unchanged at 30.4%, while adjusted EBITDA increased 23.7% to $226.7M. Chewy raised its FY26 revenue outlook but narrowed EBITDA margin guidance. CHWY stock fell 7% in morning trade, hitting a one-month low.